Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1058873 | 0.80 | RAB9A (0.64) | RAB9AALDH1A1TSHRMAPTMEN1 | |
| SCHEMBL16225691 | 0.75 | RAB9A (0.48) | RAB9AALDH1A1TSHRMAPTMEN1 | |
| SCHEMBL9506104 | 0.73 | ALDH1A1 (0.47) | RAB9AALDH1A1TSHRMAPTMEN1 | |
| SCHEMBL27056757 | 0.72 | MAOB (0.42) | RAB9AALDH1A1TSHRMAPTMEN1 | |
| SCHEMBL16225736 | 0.72 | RAB9A (0.42) | RAB9AALDH1A1TSHRMAPTMEN1 | |
| SCHEMBL31346758 | 0.71 | ALDH1A1 (0.56) | RAB9AALDH1A1TSHRMAPTMEN1 | |
| SCHEMBL11349758 | 0.71 | MAOB (0.48) | RAB9AALDH1A1TSHRMAPTMEN1 | |
| SCHEMBL27056792 | 0.71 | RAB9A (0.41) | RAB9AALDH1A1TSHRMAPTMEN1 | |
| SCHEMBL8673819 | 0.70 | ALDH1A1 (0.47) | RAB9AALDH1A1TSHRMAPTMEN1 | |
| SCHEMBL1058198 | 0.70 | MAOB (0.43) | RAB9AALDH1A1TSHRMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011140009-A1 | METHODS OF USING SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | BIOMARIN PHARMACEUTICAL INC. (US) | 2011-11-10 | — | — | WO | disclosed |